Global Gender Reassignment Surgery Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Global Gender Reassignment Surgery Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Gender reassignment surgery is also known as sex reassignment surgery or gender confirmation surgery. It is performed to transition individuals with gender dysphoria to their desired gender. Gender-affirming options may include facial surgery, top surgery, or bottom surgery.

Sex reassignment surgery is a procedure that alters the physical appearance, function, and gender of a person from the existing sexual characteristics. The transgender people who undergo the sex reassignment surgery are referred as a transsexual. Sex reassignment surgery is performed on people with severe gender dysphoria. People with gender dysphoria are properly evaluated to be mentally healthy before the surgery, which is determined by doing a mental health evaluation.

People with gender dysphoria usually suffer through the depression and anxiety of being not accepted by society and because of having the gender that he or she does not feel comfortable with. After undergoing sex reassignment surgery, a person’s feelings of anxiety and depression are expected to reduce. Before the surgery, a patient is required to undergo hormone therapy, which is important because a person is not only gets identified by his or her physical appearance, but also by the hormonal changes that he or she undergoes.

Market Overview:

The latest research study on the global Gender Reassignment Surgery market finds that the global Gender Reassignment Surgery market reached a value of USD 467.61 million in 2022. It’s expected that the market will achieve USD 1272.44 million by 2028, exhibiting a CAGR of 18.16% during the forecast period.

Negative impact in the short term

As the COVID-19 pandemic has rapidly developed around the world, scarce medical resources have been focused on the care of those infected with COVID-19, while so-called non-essential medical care has been put on hold. Gender reassignment surgeries are technically labeled as elective or nonessential, so surgeries were delayed early in the pandemic. As some gender affirming surgeries require ventilator support or blood products, some were postponed to ensure that resources were available to take care of people with severe COVID-19 infections. The scarcity and strain of medical resources are not conducive to the conduct of surgery. As per the American Society of Plastic Surgeons article titled 'The impact of COVID-19 on gender dysphoria patients' published in May 2020 reported that since gender-affirming surgeries are considered one of the elective surgeries, it has been halted or delayed. Thus, At the same time, the epidemic has also had a blow and impact on the economic ability of patients. For patients, economic opportunities for gender reassignment surgeries may be at stake due to the potential loss of jobs and income.

Long-term recovery

With the gradual implementation and maturity of epidemic prevention and control measures for vaccine promotion, elective surgeries have gradually recovered. Demand for gender reassignment surgeries remains strong and will recover rapidly as surgical capacity resumes. And in the post-pandemic era, the need for virtual medicine and telemedicine is increasing, and doctors are learning to increase the use of telemedicine and improve healthcare digitally. There are many healthcare professionals using telemedicine – exchange of medical communication by electronic communication – to improve access to care and patients' health. Through the use of digital technology to engage with patients and to augment physician education, gender-affirming telemedicine has the potential to improve equity and access to care for transgender patients.

Region Overview:

Geographically, North America held the largest market share -- 73.35% in 2022.

Company Overview:

Mount Sinai is one of the major players operating in the Gender Reassignment Surgery market, holding a share of 3.26% in 2022.

Mount Sinai

Located in New York City, the Mount Sinai Health System is an integrated health care system. The Health System is structured around eight hospital campuses, the Icahn School of Medicine at Mount Sinai and Phillips School of Nursing at Mount Sinai Beth Israel. The eight hospitals are: Mount Sinai Beth Israel, Mount Sinai Brooklyn, Mount Sinai Hospital (including Kravis Children's Hospital), Mount Sinai Queens, Mount Sinai Morningside (formerly Mount Sinai St. Luke's), Mount Sinai West (formerly Mount Sinai Roosevelt), New York Eye and Ear Infirmary of Mount Sinai, and Mount Sinai South Nassau.

Crane Center for Transgender Surgery

The Crane Center provides masculinizing surgery, non-binary surgery, facial feminization, and feminizing surgery services.

Segmentation Overview:

As for product types, the Genital segment held the largest market share in 2022.

Facial

Facial surgery to make facial features more masculine or feminine. Facial gender surgery is a combination of procedures that allow a patient to have a more gender affirming appearing face.

Breast

Breast or “Top” surgery to remove breast tissue for a more masculine appearance or enhance breast size and shape for a more feminine appearance. Breast or Top surgery is a general term to describe an operation that changes the look of a trans person's chest. Because breasts are associated with female bodies, trans men or people who were assigned to be female at birth might want to have their breasts removed or significantly reduced in size. On the other hand, trans women or people who were assigned to be male at birth but identify as more feminine can choose to have breast augmentation surgery to create a fuller figure.

Genital

Genital or “Bottom” surgery to transform and reconstruct the genitalia. Gender affirming genital surgery may consist of a combination of the following: clitoroplasty, labiaplasty, metoidioplasty, penectomy, phalloplasty, scrotoplasty, urethroplasty, vaginectomy, vaginoplasty, or placement of penile or testicular prostheses. Genital procedures performed for gender dysphoria, such as vaginoplasty, clitorolabioplasty, penectomy and orchidectomy in male-to-female transsexuals, and penile and scrotal reconstruction in female-to-male transsexuals, are the core procedures in gender reassignment surgery.

Application Overview:

The market's largest segment by application is the segment Male to Female, with a market share of 61.31% in 2022.

Male to Female

Male-to-Female (MtF) is a term used to describe the vector or direction of change of a transsexual or other transgendered person who is moving or wishing to move from a male body and gender role to (or towards) a female body and gender role. Male-to-female also refers to a person born with a male body who identifies as a woman and moves toward a social role as a woman. Those who choose to transition gender roles require access to medical services to obtain hormones and surgeries.

Female to Male

Female-to-male (FTM) indicates the direction of a physical or social transsexual or transgender transition from female to male. Sex reassignment surgery for female-to-male transgender people includes a variety of surgical procedures that alter anatomical traits to provide physical traits more comfortable to the trans man's male identity and functioning.

Key Companies in the global Gender Reassignment Surgery market covered in Chapter 3:

The Meltzer Clinic
Moein Surgical Arts
Transgender Surgery Institute of Southern California
The Gender Confirmation Center
Cedars Sinai
Rumer Cosmetic Surgery
Mount Sinai
Plastic Surgery Group Rochester
Cleveland Clinic
Crane Center for Transgender Surgery
Boston Medical Center
CNY Cosmetic & Reconstructive Surgery

In Chapter 4 and Chapter 14.2, on the basis of types, the Gender Reassignment Surgery market from 2018 to 2029 is primarily split into:

Facial
Breast
Genital

In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the Gender Reassignment Surgery market from 2018 to 2029 covers:

Male to Female
Female to Male

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2029) of the following regions are covered in Chapter 8 to Chapter 14:

North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)